Oncoloxía médica

2008

1. A single-nucleotide polymorphismin the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma

   Clinical Cancer Research, Vol. 14, Núm. 3, pp. 811-816

2. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: A randomized trial

   Journal of the National Cancer Institute, Vol. 100, Núm. 8, pp. 533-541

3. Activating KIR genes are associated with ankylosing spondylitis in Asian populations

   Human Immunology, Vol. 69, Núm. 7, pp. 437-442

4. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan

   Circulation Research, Vol. 102, Núm. 5, pp. 597-606

5. Analysis of the functional relevance of a putative regulatory SNP of PDCD1, PD1.3, associated with systemic lupus erythematosus

   Genes and Immunity, Vol. 9, Núm. 4, pp. 309-315

6. BRCA1 and acetyl-CoA carboxylase: The metabolic syndrome of breast cancer

   Molecular Carcinogenesis, Vol. 47, Núm. 2, pp. 157-163

7. Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer

   Cancer Detection and Prevention, Vol. 32, Núm. 3, pp. 236-250

8. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients

   Journal of Medical Genetics, Vol. 45, Núm. 9, pp. 557-563

9. Expression and enzyme activity of α(1,6)fucosyltransferase in human colorectal cancer

   International Journal of Cancer, Vol. 123, Núm. 3, pp. 641-646

10. Influence of HLA-B*5703 and HLA-B*1403 on susceptibility to spondyloarthropathies in the Zambian population

    Journal of Rheumatology, Vol. 35, Núm. 11, pp. 2236-2240

11. Intrahepatic cholangiocarcinoma

    Medicina clínica, Vol. 131, Núm. 17, pp. 680

12. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function

    Circulation Research, Vol. 103, Núm. 1, pp. 107-116

13. Neoadjuvant endocrine therapy for breast cancer: Past, present and future

    Anti-Cancer Drugs, Vol. 19, Núm. 4, pp. 339-347

14. Origin of renal cell carcinomas

    Clinical and Translational Oncology, Vol. 10, Núm. 11, pp. 697-712

15. Paclitaxel and cisplatin in the treatment of metastatic non-small-cell lung cancer during pregnancy

    Clinical and Translational Oncology, Vol. 10, Núm. 6, pp. 375-376

16. Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer

    Clinical and Translational Oncology, Vol. 10, Núm. 11, pp. 739-744

17. Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

    British Journal of Cancer, Vol. 98, Núm. 10, pp. 1608-1613

18. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer

    Journal of the National Cancer Institute, Vol. 100, Núm. 11, pp. 805-814

19. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain

    Clinical Cancer Research, Vol. 14, Núm. 9, pp. 2861-2869

20. Time-to-progression in breast cancer: A stratification model for clinical trials

    Breast, Vol. 17, Núm. 3, pp. 239-244